Urine CXCL10 Monitoring Trial in Kidney Transplant

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

June 6, 2025

Study Completion Date

September 26, 2025

Conditions
Kidney Transplant; ComplicationsRejection of Renal Transplant
Interventions
PROCEDURE

Kidney transplant biopsy

Elevated urine CXCL10 will trigger a study biopsy in patients randomized to the intervention arm. Subclinical rejection will be treated per protocol.

Trial Locations (9)

5000

Royal Adelaide Hospital, Adelaide

Unknown

University of Calgary, Calgary

Western University, London

University of Ottawa, Ottawa

University Health Network, University of Toronto, Toronto

Centre de recherche du CHUM (CRCHUM), Montreal

McGill, Montreal

Université Laval, Québec

R3A 1R9

University of Manitoba, Transplant Manitoba Adult Kidney Program, Winnipeg

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Canadian National Transplant Research Program

OTHER

lead

University of Manitoba

OTHER

NCT03206801 - Urine CXCL10 Monitoring Trial in Kidney Transplant | Biotech Hunter | Biotech Hunter